Daniel J Schoen receives funding from the Natural Sciences and Research Council of Canada. McGill University provides funding ...
"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
A Sydney-based data scientist used AI to create a personalised cancer vaccine for his dog, leading to significant tumour reduction.
Excavations on Peru's coast reveal pre-Inca parrot husbandry, radiocarbon-dated to 1100-1450, and long-distance transport from the Amazon basin.
Trained on 9 trillion DNA base pairs from every domain of life, the Evo 2 model can predict disease-causing mutations, identify genomic features and generate entirely new genetic sequences.
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
To use this evidence, investigators typically must grow the larvae until adulthood in a laboratory setting and then identify ...
The compounding power of Moore's Law allowed for the internet the smartphone and AI. Now Ian says it's being applied to the ...
AGBT is also, increasingly, a showcase for instruments for spatial biology, a fast-growing field that involves pinpointing the location of RNA and protein molecules en masse. Tarbox calls the meeting ...
Around the world, scientists are exploring an unexpected solution to the growing data crisis: storing digital information in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results